MedPath

Rimtuzalcap

Generic Name
Rimtuzalcap
Drug Type
Small Molecule
Chemical Formula
C18H24F2N6O
CAS Number
2167246-24-2
Unique Ingredient Identifier
USO2D5J77R

Overview

Rimtuzalcap is a novel modulator of small-conductance calcium-activated potassium channels that is under investigation for the treatment of essential tremor.

Background

Rimtuzalcap is a novel modulator of small-conductance calcium-activated potassium channels that is under investigation for the treatment of essential tremor.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Phase 2
Withdrawn
Posted: 2020/03/10
Sponsor:
Cadent Therapeutics
Phase 2
Completed
Posted: 2018/09/28
Sponsor:
Cadent Therapeutics

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath